» Articles » PMID: 33809691

Advances in Nanomaterial-Mediated Photothermal Cancer Therapies: Toward Clinical Applications

Overview
Journal Biomedicines
Date 2021 Apr 3
PMID 33809691
Citations 72
Authors
Affiliations
Soon will be listed here.
Abstract

Photothermal therapy (PTT) has attracted extensive research attention as a noninvasive and selective treatment strategy for numerous cancers. PTT functions via photothermal effects induced by converting light energy into heat on near-infrared laser irradiation. Despite the great advances in PTT for cancer treatment, the photothermal therapeutics using laser devise only or non-specific small molecule PTT agents has been limited because of its low photothermal conversion efficiency, concerns about the biosafety of the photothermal agents, their low tumor accumulation, and a heat resistance of specific types of cancer. Using nanomaterials as PTT agents themselves, or for delivery of PTT agents, offers improved therapeutic outcomes with fewer side effects through enhanced photothermal conversion efficiency, accumulation of the PTT agent in the tumor tissue, and, by extension, through combination with other therapies. Herein, we review PTT's current clinical progress and present the future outlooks for clinical applications. To better understand clinical PTT applications, we describe nanomaterial-mediated photothermal effects and their mechanism of action in the tumor microenvironment. This review also summarizes recent studies of PTT alone or in combination with other therapies. Overall, innovative and strategically designed PTT platforms are promising next-generation noninvasive cancer treatments to move closer toward clinical applications.

Citing Articles

BSA@IR780-loaded mesoporous polydopamine nanoparticles with enhanced photostability for multimodal imaging and photothermal therapy of tumors.

Yang S, Diao Y, Hang L, Qu H, Fang L, Guo W Nanoscale Adv. 2025; .

PMID: 40007568 PMC: 11848625. DOI: 10.1039/d5na00008d.


Preclinical advance in nanoliposome-mediated photothermal therapy in liver cancer.

Tang L, Yang X, He L, Zhu C, Chen Q Lipids Health Dis. 2025; 24(1):31.

PMID: 39891269 PMC: 11783920. DOI: 10.1186/s12944-024-02429-x.


Femtosecond Laser-Induced Photothermal Effects of Ultrasmall Plasmonic Gold Nanoparticles on the Viability of Human Hepatocellular Carcinoma HepG2 Cells.

Santhosh P, Hristova-Panusheva K, Petrov T, Stoychev L, Krasteva N, Genova J Cells. 2025; 13(24.

PMID: 39768227 PMC: 11675025. DOI: 10.3390/cells13242139.


Orchestrating cancer therapy: Recent advances in nanoplatforms harmonize immunotherapy with multifaceted treatments.

Xu R, Lin P, Zheng J, Lin Y, Mai Z, Lu Y Mater Today Bio. 2025; 30:101386.

PMID: 39742149 PMC: 11683241. DOI: 10.1016/j.mtbio.2024.101386.


Leveraging Femtosecond Laser Ablation for Tunable Near-Infrared Optical Properties in MoS-Gold Nanocomposites.

Zavidovskiy I, Martynov I, Tselikov D, Syuy A, Popov A, Novikov S Nanomaterials (Basel). 2024; 14(23).

PMID: 39683349 PMC: 11643533. DOI: 10.3390/nano14231961.


References
1.
Knavel E, Brace C . Tumor ablation: common modalities and general practices. Tech Vasc Interv Radiol. 2013; 16(4):192-200. PMC: 4281168. DOI: 10.1053/j.tvir.2013.08.002. View

2.
Zou L, Wang H, He B, Zeng L, Tan T, Cao H . Current Approaches of Photothermal Therapy in Treating Cancer Metastasis with Nanotherapeutics. Theranostics. 2016; 6(6):762-72. PMC: 4860886. DOI: 10.7150/thno.14988. View

3.
Issels R . Hyperthermia adds to chemotherapy. Eur J Cancer. 2008; 44(17):2546-54. DOI: 10.1016/j.ejca.2008.07.038. View

4.
Mouratidis P, Rivens I, Ter Haar G . A study of thermal dose-induced autophagy, apoptosis and necroptosis in colon cancer cells. Int J Hyperthermia. 2015; 31(5):476-88. DOI: 10.3109/02656736.2015.1029995. View

5.
Vogl T, Muller P, Hammerstingl R, Weinhold N, Mack M, Philipp C . Malignant liver tumors treated with MR imaging-guided laser-induced thermotherapy: technique and prospective results. Radiology. 1995; 196(1):257-65. DOI: 10.1148/radiology.196.1.7540310. View